Compare Immunovant Inc. Common Stock (IMVT) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Lucid Group Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Lucid Group Inc trades at $3.84 (market cap $1.53B). The key difference: Immunovant Inc. Common Stock is far larger — about 4.3× Lucid Group Inc's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Lucid Group Inc for 45 Days on average.
| IMVT | LCID | |
|---|---|---|
Market Cap | $6.62B | $1.53B |
Volume | 1,131,364 | 12,739,758 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $21.92 |
52-Week Low | $17.03 | $3.82 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $5.72B | $4.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lucid Group (LCID) trades at $3.82, down 8.17% with bearish technical signals and negative financial metrics. The company reported significant losses with -249.21% net income margin and missed earnings expectations for three consecutive quarters. Recent developments include strategic partnerships for autonomous vehicles but also product delays and cash burn concerns.
The outlook remains challenging with substantial financial losses and negative cash flow, though analyst consensus suggests potential upside to $7.60. Key risks include execution delays, high cash burn, and competitive pressures in the EV market. The stock faces make-or-break execution challenges in its turnaround efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
